journal article·2020-09-02

Triamcinolone–Gold Nanoparticles Repolarize Synoviocytes and Macrophages in an Inflamed Synovium

Jun-Young Park, Song Kwon, Sang-Hyun Kim, Youn Joo Kang, Dongwoo Khang

ACS Applied Materials & Interfaces· Volume 12· Issue 35
Publisher page

Abstract

Understanding the crosstalk between synoviocytes and macrophages is very important for the development of strategies to regulate inflammatory responses in an inflamed synovium. Simultaneous regulation of the pro- and anti-inflammatory responses of synoviocytes and macrophages (repolarization) is critical for the treatment of arthritis. Thus, the immune regulatory functions of an ideal nanodrug should not only decrease the pro-inflammatory response but also effectively increase the anti-inflammatory response. In this study, crosstalk between synoviocytes and macrophages was found to be significantly involved in the activation and deactivation of inflammatory responses in the synovium. Interestingly, a developed triamcinolone-gold nanoparticle (Triam-AuNP) complex both decreased the pro-inflammatory responses and increased the anti-inflammatory responses of fibroblast-like synoviocytes (FLSs) and macrophages via repolarization of macrophages from the M1 to the M2 phenotype. In contrast, triamcinolone alone only decreased the pro-inflammatory responses of FLSs and macrophages without upregulating their anti-inflammatory responses. In vitro (human), ex vivo (human), and in vivo (mouse) analyses clearly indicated that Triam-AuNPs effectively regulated the expression of both pro- and anti-inflammatory cytokines in FLSs and effectively repolarized activity of macrophages in the inflamed synovium. Furthermore, Triam-AuNPs significantly promoted cartilage regeneration, whereas triamcinolone alone did not induce either FLS anti-inflammatory activity or macrophage repolarization.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Autoimmune and Inflammatory Disorders Research · Extracellular vesicles in disease · Kawasaki Disease and Coronary Complications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Gachon Advanced Institute for Health Science & Technology (GAIHST), Gachon University, Incheon 21999, South Korea

Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon 21999, South Korea

Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu 41944, South Korea

Department of Rehabilitation Medicine, Nowon Eulji Medical Center, Eulji University, Seoul 01830, South Korea

Department of Physiology, College of Medicine, Gachon University, Incheon 21999, South Korea

Funding

National Research Foundation of Korea · Eulji University

References (42)

Show source-provided references
1. 10.1038/boneres.2015.4010.1038/boneres.2015.40 ↗
2. 10.1016/j.semarthrit.2018.06.00210.1016/j.semarthrit.2018.06.002 ↗
3. 10.1093/rheumatology/keh07310.1093/rheumatology/keh073 ↗
4. 10.1007/s40265-019-01083-310.1007/s40265-019-01083-3 ↗
5. 10.1016/j.arthro.2018.02.02210.1016/j.arthro.2018.02.022 ↗
6. 10.1093/rheumatology/keh10210.1093/rheumatology/keh102 ↗
7. Woolf A. D. · Bull. W. H. O. · 2003 · 81 · 646
8. 10.1111/j.0105-2896.2009.00859.x10.1111/j.0105-2896.2009.00859.x ↗
9. 10.1016/j.clim.2004.12.00910.1016/j.clim.2004.12.009 ↗
10. 10.1186/ar8610.1186/ar86 ↗
11. 10.3390/ijms1906180110.3390/ijms19061801 ↗
12. 10.7150/ijbs.887910.7150/ijbs.8879 ↗
13. 10.1039/C6CS00636A10.1039/C6CS00636A ↗
14. 10.3389/fimmu.2019.0000310.3389/fimmu.2019.00003 ↗
15. 10.1038/nrrheum.2016.9110.1038/nrrheum.2016.91 ↗
16. 10.1007/s00018-009-0053-z10.1007/s00018-009-0053-z ↗
17. 10.3389/fimmu.2019.0199810.3389/fimmu.2019.01998 ↗
18. 10.1021/nl202559p10.1021/nl202559p ↗
19. 10.1021/nn301215q10.1021/nn301215q ↗
20. 10.1021/acsnano.9b0454110.1021/acsnano.9b04541 ↗
21. 10.1039/C7BM00254H10.1039/C7BM00254H ↗
22. 10.2147/IJN.S14212210.2147/IJN.S142122 ↗
23. 10.1039/C5TB01693B10.1039/C5TB01693B ↗
24. 10.1002/art.1077710.1002/art.10777 ↗
25. 10.1155/2014/56145910.1155/2014/561459 ↗
26. 10.1016/S1357-4310(00)01686-510.1016/S1357-4310(00)01686-5 ↗
27. 10.2165/00003495-199856001-0000210.2165/00003495-199856001-00002 ↗
28. 10.1136/ard.53.11.76810.1136/ard.53.11.768 ↗
29. 10.1136/ard.58.11.69110.1136/ard.58.11.691 ↗
30. 10.1093/rheumatology/keg03710.1093/rheumatology/keg037 ↗
31. 10.3389/fimmu.2011.0005210.3389/fimmu.2011.00052 ↗
32. 10.1007/s00281-017-0631-310.1007/s00281-017-0631-3 ↗
33. 10.1021/acsnano.8b0878510.1021/acsnano.8b08785 ↗
34. 10.1002/adhm.20190154110.1002/adhm.201901541 ↗
35. 10.1002/art.2750310.1002/art.27503 ↗
36. 10.1006/clin.1994.116410.1006/clin.1994.1164 ↗
37. 10.1084/jem.2005047310.1084/jem.20050473 ↗
38. 10.1002/art.2770110.1002/art.27701 ↗
39. 10.1038/s41565-018-0254-410.1038/s41565-018-0254-4 ↗
40. 10.1002/art.3793210.1002/art.37932 ↗
41. 10.1038/nprot.2007.17310.1038/nprot.2007.173 ↗
42. 10.1093/rheumatology/kev36110.1093/rheumatology/kev361 ↗